603363 傲農生物
按盤價 
3.760 -0.140 (-3.590%) | 2023/09 - 九個月 人民幣(K¥) | 與去年同期 比較 | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | 2019/12 人民幣(K¥) | ||
| 營業總收入 | 15,176,656 | -1.47% | 21,613,040 | 18,038,160 | 11,517,166 | 5,788,080 | |
| 減：營業總成本 | 16,785,291 | 3.51% | 22,475,331 | 19,302,979 | 10,468,321 | 5,677,881 | |
| 其中:營業成本 | 15,510,008 | 4.11% | 20,664,799 | 17,780,505 | 9,529,061 | 5,050,516 | |
| 財務費用 | 366,268 | -9.14% | 532,474 | 431,976 | 179,164 | 94,220 | |
| 資產減值損失 | (72,143) | -19,383.68% | (330,236) | (456,803) | (6,569) | (939) | |
| 公允價值變動收益 | 1,757 | -200.00% | (105,324) | (31,496) | (23,685) | -- | |
| 投資收益 | 42,318 | -449.68% | (14,440) | (28,477) | 5,890 | (6,942) | |
| 其中：對聯營企業和合營企業的投資收益 | (9,609) | 1.51% | (9,492) | (29,725) | (5,063) | (6,814) | |
| 營業利潤 | (1,590,222) | 87.79% | (1,311,398) | (1,806,657) | 965,622 | 78,067 | |
| 利潤總額 | (1,545,982) | 88.06% | (1,295,035) | (1,821,577) | 970,519 | 77,741 | |
| 減：所得稅費用 | (12,489) | -81.80% | (68,085) | 29,343 | (23,086) | (22,615) | |
| 淨利潤 | (1,533,492) | 103.53% | (1,226,951) | (1,850,920) | 993,605 | 100,356 | |
| 減：非控股權益 | (243,604) | 34.79% | (187,924) | (331,048) | 420,616 | 71,200 | |
| 股東淨利潤 | (1,289,888) | 125.22% | (1,039,026) | (1,519,872) | 572,989 | 29,156 | |
市場價值指標 | |||||||
| 每股收益 (元) * | -1.490 | 96.05% | -1.340 | -2.340 | 0.950 | 0.050 | |
| 每股派息 (元) * | -- | -- | -- | -- | 0.250 | 0.000 | |
| 每股淨資產 (元) * | 1.223 | -64.70% | 2.874 | -- | 4.068 | 1.907 | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 23/04/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
